Krystal Biotech Inc KRYS
News
Jeune Aesthetics Announces Phase 1 Positive Interim Safety and Efficacy Results for KB301 in the Treatment of Lateral Canthal Lines and Dynamic Wrinkles of the Décolleté
Krystal Biotech Announces Second Quarter 2024 Financial Results and Provides Business Updates
Krystal Biotech to Report Second Quarter 2024 Financial Results on August 5, 2024